2021
DOI: 10.2147/ijn.s294653
|View full text |Cite
|
Sign up to set email alerts
|

Nanoemulgel, an Innovative Carrier for Diflunisal Topical Delivery with Profound Anti-Inflammatory Effect: in vitro and in vivo Evaluation

Abstract: Purpose Rheumatoid arthritis is an autoimmune disorder that directly affects joints. However, other body organs including heart, eyes, skin, blood vessels and lungs may also be affected. The purpose of this study was to design and evaluate a nanoemulgel formulation of diflunisal (DIF) and solubility enhanced diflunisal (DIF-IC) for enhanced topical anti-inflammatory activity. Methodology Nanoemulsion formulations of both DIF and DIF-IC were prepared and incorporated in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(25 citation statements)
references
References 52 publications
0
23
0
2
Order By: Relevance
“…This indicates a non-Newtonian, pseudoplastic property with thixotropic behaviour for developed TAM-NEGs [ 42 , 43 ]. This is appropriate behaviour for pharmaceutical formulations designed for topical skin treatment [ 34 , 44 , 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…This indicates a non-Newtonian, pseudoplastic property with thixotropic behaviour for developed TAM-NEGs [ 42 , 43 ]. This is appropriate behaviour for pharmaceutical formulations designed for topical skin treatment [ 34 , 44 , 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…CEONLC formulations were gelled using xanthan gum as a gelling agent according to the method described by 47 . For the preparation of the gel base of xanthan gum, 3 mg of the gum was added to 100 ml of deionized water and stirred continuously to form a gel base, followed by pH adjustment with triethanolamine.…”
Section: Methodsmentioning
confidence: 99%
“…Also, a xanthan gum-based nanogel was designed and formulated as DDS for diflunisal (DIF) for topical antiinflammatory activity to treat rheumatoid arthritis. This nanogel showed an increased drug bioavailability and high drug release profile, ensured a modulate and localized drug effect by maintaining a higher degree of retention of payload, therefore providing a prolonged effect (Bashir et al, 2021). Hence, this approach can be an attractive alternative compared with conventional topical formulation or even a promising substitute to oral DDS.…”
Section: Nanogelsmentioning
confidence: 99%